<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35925074</PMID><DateCompleted><Year>2022</Year><Month>08</Month><Day>08</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2731-7099</ISSN><JournalIssue CitedMedium="Internet"><Volume>63</Volume><Issue>8</Issue><PubDate><Year>2022</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Innere Medizin (Heidelberg, Germany)</Title><ISOAbbreviation>Inn Med (Heidelb)</ISOAbbreviation></Journal><ArticleTitle>[Post-COVID syndrome with fatigue and exercise intolerance: myalgic encephalomyelitis/chronic fatigue syndrome].</ArticleTitle><Pagination><StartPage>830</StartPage><EndPage>839</EndPage><MedlinePgn>830-839</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00108-022-01369-x</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">A&#xa0;sizable part of post-COVID syndrome meets the diagnostic criteria for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). A&#xa0;doubling of cases of ME/CFS within the next years is therefore projected.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Presentation of the current state of knowledge on ME/CFS.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">Unsystematic review of the literature and of own contributions in research and patient care.</AbstractText><AbstractText Label="RESULTS AND CONCLUSIONS" NlmCategory="CONCLUSIONS">ME/CFS is a&#xa0;neuroimmunological disease, mostly infection-induced, usually persisting throughout life. Clinically it is characterized by fatigue lasting at least 6&#xa0;months and the defining core feature of exercise intolerance (post-exertional malaise, PEM). Exercise intolerance is defined as a&#xa0;worsening of symptoms after (even mild) everyday exertion, which usually begins after several hours or on the following day, is still noticeable at least 14&#xa0;h after exertion, and often lasts for several days (up to weeks or longer). Furthermore, ME/CFS is characterized by pain, disturbances of sleep, thinking and memory, and dysregulation of the circulatory, endocrine, and immune systems. As a&#xa0;separate clinical entity, ME/CFS should be distinguished from chronic fatigue, which occurs as a&#xa0;symptom of a&#xa0;range of very different diseases. The diagnosis of ME/CFS is made clinically using established international diagnostic criteria and requires careful stepwise diagnosis to exclude other diagnoses. A&#xa0;causal therapy for ME/CFS has not been established; the focus is on symptoms relief, treatment of the often accompanying orthostatic intolerance, and assistance with anticipatory energy management (pacing).</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Renz-Polster</LastName><ForeName>Herbert</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>, Rohrmoos&#xa0;10, 88267, Vogt, Deutschland. herbert.renz-polster@posteo.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scheibenbogen</LastName><ForeName>Carmen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Charit&#xe9; Fatigue Centrum der Charit&#xe9;&#xa0;- Universit&#xe4;tsmedizin Berlin, Campus Virchow-Klinikum, Augustenburger Platz 1 (S&#xfc;dstr. 2), 13353, Berlin, Deutschland. carmen.scheibenbogen@charite.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>ger</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><VernacularTitle>Post-COVID-Syndrom mit Fatigue und Belastungsintoleranz: Myalgische Enzephalomyelitis bzw. Chronisches Fatigue-Syndrom.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2022</Year><Month>07</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Inn Med (Heidelb)</MedlineTA><NlmUniqueID>9918384885306676</NlmUniqueID><ISSNLinking>2731-7080</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015673" MajorTopicYN="Y">Fatigue Syndrome, Chronic</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010146" MajorTopicYN="N">Pain</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="ger"><AbstractText Label="ZUSAMMENFASSUNG" NlmCategory="UNASSIGNED">HINTERGRUND: Ein erheblicher Teil der Verl&#xe4;ufe des Post-COVID-Syndroms (COVID &#x201e;coronavirus disease&#x201c;) erf&#xfc;llt die Diagnosekriterien f&#xfc;r Myalgische Enzephalomyelitis/Chronisches Fatigue-Syndrom (ME/CFS). In den n&#xe4;chsten Jahren muss deshalb mit einer Verdopplung der Zahl der von ME/CFS Betroffenen gerechnet werden.</AbstractText><AbstractText Label="ZIEL DER ARBEIT" NlmCategory="UNASSIGNED">Darstellung des aktuellen Wissensstands zu ME/CFS.</AbstractText><AbstractText Label="MATERIAL UND METHODEN" NlmCategory="METHODS">Unsystematisches Review der Literatur sowie eigener Arbeiten in Forschung und Patient*innenversorgung.</AbstractText><AbstractText Label="ERGEBNISSE UND SCHLUSSFOLGERUNG" NlmCategory="UNASSIGNED">Bei ME/CFS handelt es sich um eine zumeist infektinduzierte, in der Regel lebenslang persistierende neuroimmunologische Erkrankung mit mindestens 6&#xa0;Monate anhaltender Fatigue und dem definierenden Kernmerkmal der Belastungsintoleranz (&#x201e;post-exertional malaise&#x201c; [PEM]). Darunter versteht man eine nach (auch leichter) Alltagsanstrengung auftretende Verschlechterung der Beschwerden, die meist erst nach mehreren Stunden oder am Folgetag einsetzt, mindestens 14&#x202f;h nach Belastung noch sp&#xfc;rbar ist und oft mehrere Tage (bis Wochen oder l&#xe4;nger) anh&#xe4;lt. Des Weiteren bestehen bei ME/CFS Schmerzen, St&#xf6;rungen von Schlaf, Denk- und Merkf&#xe4;higkeit sowie Fehlregulationen von Kreislauf, Hormon- und Immunsystem. Als eigenst&#xe4;ndige klinische Entit&#xe4;t ist ME/CFS von der chronischen Fatigue abzugrenzen, die als Symptom bei ganz unterschiedlichen Erkrankungen auftritt. Die Diagnose ME/CFS wird anhand etablierter internationaler Diagnosekriterien klinisch gestellt und erfordert zum Ausschluss anderer Diagnosen eine sorgf&#xe4;ltige Stufendiagnostik. Eine kausale Therapie f&#xfc;r ME/CFS ist nicht etabliert, im Vordergrund steht die Linderung der Beschwerden, die Behandlung der oft begleitenden orthostatischen Intoleranz sowie die Unterst&#xfc;tzung beim vorausschauenden Energiemanagement (&#x201e;pacing&#x201c;).</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.</CopyrightInformation></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Chronic fatigue syndrome</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Pacing</Keyword><Keyword MajorTopicYN="N">Post exertional malaise</Keyword><Keyword MajorTopicYN="N">Severe acute respiratory syndrome coronavirus type&#xa0;2 (SARS-CoV-2)</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>6</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>4</Day><Hour>11</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>7</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35925074</ArticleId><ArticleId IdType="pmc">PMC9281337</ArticleId><ArticleId IdType="doi">10.1007/s00108-022-01369-x</ArticleId><ArticleId IdType="pii">10.1007/s00108-022-01369-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Choutka J, Jansari V, Hornig M, Iwasaki A. Unexplained post-acute infection syndromes. Nat Med. 2022;28(5):911&#x2013;923. doi: 10.1038/s41591-022-01810-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01810-6</ArticleId><ArticleId IdType="pubmed">35585196</ArticleId></ArticleIdList></Reference><Reference><Citation>Renz-Polster H, Hattesohl D, Behrends U, Scheibenbogen C. Myalgische Enzephalomyelitis/Chronisches Fatigue-Syndrom und Belastungsintoleranz. In: Formmhold J, Sch&#xfc;ller PO, editors. Das Post Covid Syndrom. Medizinisch Wissenschaftliche Verlagsgesellschaft; 2022.</Citation></Reference><Reference><Citation>Kedor C, Freitag H, Meyer-Arndt L, Wittke K, Zoller T, Steinbeis F, et al. Chronic COVID-19 Syndrome and Chronic Fatigue Syndrome (ME/CFS) following the first pandemic wave in Germany&#x2014;a&#xa0;first analysis of a&#xa0;prospective observational study. 2021.</Citation></Reference><Reference><Citation>Komaroff AL, Bateman L. Will COVID-19 lead to myalgic encephalomyelitis/chronic fatigue syndrome? Front Med. 2021 doi: 10.3389/fmed.2020.606824/full.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2020.606824/full</ArticleId><ArticleId IdType="pmc">PMC7848220</ArticleId><ArticleId IdType="pubmed">33537329</ArticleId></ArticleIdList></Reference><Reference><Citation>Tokumasu K, Honda H, Sunada N, Sakurada Y, Matsuda Y, Yamamoto K, et al. Clinical Characteristics of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Diagnosed in Patients with Long COVID. Medicina (Mex) 2022;58(7):850. doi: 10.3390/medicina58070850.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina58070850</ArticleId><ArticleId IdType="pmc">PMC9325226</ArticleId><ArticleId IdType="pubmed">35888568</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason LA, Mirin AA. Updating the National Academy of Medicine ME/CFS prevalence and economic impact figures to account for population growth and inflation. Fatigue Biomed Health Behav. 2021;9(1):9&#x2013;13. doi: 10.1080/21641846.2021.1878716.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21641846.2021.1878716</ArticleId></ArticleIdList></Reference><Reference><Citation>Renz-Polster H, Tremblay ME, Bienzle D, Fischer JE. The pathobiology of myalgic encephalomyelitis/chronic fatigue syndrome: the case for neuroglial failure. Front Cell Neurosci. 2022 doi: 10.3389/fncel.2022.888232.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2022.888232</ArticleId><ArticleId IdType="pmc">PMC9124899</ArticleId><ArticleId IdType="pubmed">35614970</ArticleId></ArticleIdList></Reference><Reference><Citation>Committee on the Diagnostic Criteria for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, Board on the Health of Select Populations, Institute of Medicine. Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness [Internet]. Washington (DC): National Academies Press (US); 2015 [cited 2022&#xa0;May 2]. (The National Academies Collection: Reports funded by National Institutes of Health). Available from: http://www.ncbi.nlm.nih.gov/books/NBK274235/</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff AL, Lipkin WI. Insights from myalgic encephalomyelitis/chronic fatigue syndrome May help unravel the pathogenesis of post-acute COVID-19 syndrome. Trends Mol Med. 2021 doi: 10.1016/j.molmed.2021.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2021.06.002</ArticleId><ArticleId IdType="pmc">PMC8180841</ArticleId><ArticleId IdType="pubmed">34175230</ArticleId></ArticleIdList></Reference><Reference><Citation>van Campen L, Verheugt FWA, Rowe PC, Visser FC. Cerebral blood flow is reduced in ME/CFS during head-up tilt testing even in the absence of hypotension or tachycardia: A quantitative, controlled study using Doppler echography. Clin Neurophysiol. 2020;5:50&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7044650</ArticleId><ArticleId IdType="pubmed">32140630</ArticleId></ArticleIdList></Reference><Reference><Citation>Melamed KH, Santos M, Oliveira RKF, Urbina MF, Felsenstein D, Opotowsky AR, et al. Unexplained exertional intolerance associated with impaired systemic oxygen extraction. Eur J Appl Physiol. 2019;119(10):2375&#x2013;2389. doi: 10.1007/s00421-019-04222-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00421-019-04222-6</ArticleId><ArticleId IdType="pubmed">31493035</ArticleId></ArticleIdList></Reference><Reference><Citation>Joseph P, Arevalo C, Oliveira RKF, Faria-Urbina M, Felsenstein D, Oaklander AL, et al. Insights from invasive cardiopulmonary exercise testing of patients with myalgic encephalomyelitis/chronic fatigue syndrome. Chest. 2021 doi: 10.1016/j.chest.2021.01.082.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2021.01.082</ArticleId><ArticleId IdType="pmc">PMC8727854</ArticleId><ArticleId IdType="pubmed">33577778</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh I, Joseph P, Heerdt PM, Cullinan M, Lutchmansingh DD, Gulati M, et al. Persistent exertional intolerance after COVID-19: insights from invasive cardiopulmonary exercise testing. Chest. 2021 doi: 10.1016/j.chest.2021.08.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2021.08.010</ArticleId><ArticleId IdType="pmc">PMC8354807</ArticleId><ArticleId IdType="pubmed">34389297</ArticleId></ArticleIdList></Reference><Reference><Citation>Novak P, Mukerji SS, Alabsi HS, Systrom D, Marciano SP, Felsenstein D, et al. Multisystem involvement in post-acute sequelae of coronavirus disease 19. Ann Neurol. 2022;91(3):367&#x2013;379. doi: 10.1002/ana.26286.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.26286</ArticleId><ArticleId IdType="pmc">PMC9011495</ArticleId><ArticleId IdType="pubmed">34952975</ArticleId></ArticleIdList></Reference><Reference><Citation>van Campen C, Rowe PC, Visser FC. Orthostatic symptoms and reductions in cerebral blood flow in long-haul COVID-19 patients: similarities with myalgic encephalomyelitis/chronic fatigue syndrome. Ann Univ Mariae Curie Sklodowska [Med] 2022;58(1):28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8778312</ArticleId><ArticleId IdType="pubmed">35056336</ArticleId></ArticleIdList></Reference><Reference><Citation>Loebel M, Grabowski P, Heidecke H, Bauer S, Hanitsch LG, Wittke K, et al. Antibodies to &#x3b2; adrenergic and muscarinic cholinergic receptors in patients with Chronic Fatigue Syndrome. Brain Behav Immun. 2016;52:32&#x2013;39. doi: 10.1016/j.bbi.2015.09.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2015.09.013</ArticleId><ArticleId IdType="pubmed">26399744</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallukat G, Hohberger B, Wenzel K, F&#xfc;rst J, Schulze-Rothe S, Wallukat A, et al. Functional autoantibodies against G-protein coupled receptors in patients with persistent Long-COVID-19 symptoms. J Transl Autoimmun. 2021;4:100100. doi: 10.1016/j.jtauto.2021.100100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtauto.2021.100100</ArticleId><ArticleId IdType="pmc">PMC8049853</ArticleId><ArticleId IdType="pubmed">33880442</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheibenbogen C, Loebel M, Freitag H, Krueger A, Bauer S, Antelmann M, et al. Immunoadsorption to remove &#x3b2;2 adrenergic receptor antibodies in Chronic Fatigue Syndrome CFS/ME. PLoS ONE. 2018;13(3):e0193672. doi: 10.1371/journal.pone.0193672.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0193672</ArticleId><ArticleId IdType="pmc">PMC5854315</ArticleId><ArticleId IdType="pubmed">29543914</ArticleId></ArticleIdList></Reference><Reference><Citation>Hennig T, Prusty AB, Kaufer BB, Whisnant AW, Lodha M, Enders A, et al. Selective inhibition of miRNA processing by a&#xa0;herpesvirus-encoded miRNA. Nature. 2022;605(7910):539&#x2013;544. doi: 10.1038/s41586-022-04667-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04667-4</ArticleId><ArticleId IdType="pubmed">35508655</ArticleId></ArticleIdList></Reference><Reference><Citation>Hohberger B, Harrer T, Mardin C, Kruse F, Hoffmanns J, Rogge L, et al. Neutralization of autoantibodies targeting G-protein coupled receptors improves capillary impairment and fatigue symptoms after COVID-19 infection. Rochester: Social Science Research Network; 2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8637609</ArticleId><ArticleId IdType="pubmed">34869451</ArticleId></ArticleIdList></Reference><Reference><Citation>J&#xe4;kel B, Kedor C, Grabowski P, Wittke K, Thiel S, Scherbakov N, et al. Hand grip strength and fatigability: correlation with clinical parameters and diagnostic suitability in ME/CFS. J Transl Med. 2021;19(1):159. doi: 10.1186/s12967-021-02774-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-021-02774-w</ArticleId><ArticleId IdType="pmc">PMC8056497</ArticleId><ArticleId IdType="pubmed">33874961</ArticleId></ArticleIdList></Reference><Reference><Citation>Pendergrast T, Brown A, Sunnquist M, Jantke R, Newton JL, Strand EB, et al. Housebound versus nonhousebound patients with myalgic encephalomyelitis and chronic fatigue syndrome. Chronic Illn. 2016;12(4):292&#x2013;307. doi: 10.1177/1742395316644770.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1742395316644770</ArticleId><ArticleId IdType="pmc">PMC5464362</ArticleId><ArticleId IdType="pubmed">27127189</ArticleId></ArticleIdList></Reference><Reference><Citation> Unemployment and work disability in individuals with chronic fatigue syndrome/myalgic encephalomyelitis: a&#xa0;community-based cross-sectional study from Spain. https://www.springermedizin.de/unemployment-and-work-disability-in-individuals-with-chronic-fat/16866134. Zugegriffen: 2. Mai 2022</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6599355</ArticleId><ArticleId IdType="pubmed">31253111</ArticleId></ArticleIdList></Reference><Reference><Citation>Nacul L, O&#x2019;Boyle S, Palla L, Nacul FE, Mudie K, Kingdon CC, et al. How myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) progresses: the natural history of ME/CFS. Front Neurol. 2022 doi: 10.3389/fneur.2020.00826.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.00826</ArticleId><ArticleId IdType="pmc">PMC7431524</ArticleId><ArticleId IdType="pubmed">32849252</ArticleId></ArticleIdList></Reference><Reference><Citation>Nacul L, Authier FJ, Scheibenbogen C, Lorusso L, Helland IB, Martin JA, et al. European network on myalgic encephalomyelitis/chronic fatigue syndrome (EUROMENE): expert consensus on the diagnosis, service provision, and care of people with ME/CFS in europe. Med Kaunas Lith. 2021;57(5):510.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8161074</ArticleId><ArticleId IdType="pubmed">34069603</ArticleId></ArticleIdList></Reference><Reference><Citation>Carruthers BM, Jain AK, De Meirleir KL, Peterson DL, Klimas NG, Lerner AM, et al. Myalgic encephalomyelitis/chronic fatigue syndrome. J Chronic Fatigue Syndr. 2003;11(1):7&#x2013;115. doi: 10.1300/J092v11n01_02.</Citation><ArticleIdList><ArticleId IdType="doi">10.1300/J092v11n01_02</ArticleId></ArticleIdList></Reference><Reference><Citation>Bested AC, Marshall LM. Review of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: an evidence-based approach to diagnosis and management by clinicians. Rev Environ Health. 2015;30(4):223&#x2013;249. doi: 10.1515/reveh-2015-0026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/reveh-2015-0026</ArticleId><ArticleId IdType="pubmed">26613325</ArticleId></ArticleIdList></Reference><Reference><Citation>Guenther S, Loebel M, Mooslechner AA, Knops M, Hanitsch LG, Grabowski P, et al. Frequent IgG subclass and mannose binding lectin deficiency in patients with chronic fatigue syndrome. Hum Immunol. 2015;76(10):729&#x2013;735. doi: 10.1016/j.humimm.2015.09.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.humimm.2015.09.028</ArticleId><ArticleId IdType="pubmed">26429318</ArticleId></ArticleIdList></Reference><Reference><Citation>Vernino S, Bourne KM, Stiles LE, Grubb BP, Fedorowski A, Stewart JM, et al. Postural orthostatic tachycardia syndrome (POTS): state of the science and clinical care from a&#xa0;2019 National Institutes of Health Expert Consensus Meeting&#x2014;Part 1. J&#xa0;Auton Nerv Syst. 2021 doi: 10.1016/j.autneu.2021.102828.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autneu.2021.102828</ArticleId><ArticleId IdType="pmc">PMC8455420</ArticleId><ArticleId IdType="pubmed">34144933</ArticleId></ArticleIdList></Reference><Reference><Citation>Raj SR, Bourne KM, Stiles LE, Miglis MG, Cortez MM, Miller AJ, et al. Postural orthostatic tachycardia syndrome (POTS): Priorities for POTS care and research from a&#xa0;2019 National Institutes of Health Expert Consensus Meeting&#x2014;Part 2. Auton Neurosci Basic Clin. 2021;235:102836. doi: 10.1016/j.autneu.2021.102836.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autneu.2021.102836</ArticleId><ArticleId IdType="pmc">PMC8455430</ArticleId><ArticleId IdType="pubmed">34246578</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro-Marrero J, S&#xe1;ez-Franc&#xe0;s N, Santillo D, Alegre J. Treatment and management of chronic fatigue syndrome/myalgic encephalomyelitis: all roads lead to Rome. Br J Pharmacol. 2017;174(5):345&#x2013;369. doi: 10.1111/bph.13702.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.13702</ArticleId><ArticleId IdType="pmc">PMC5301046</ArticleId><ArticleId IdType="pubmed">28052319</ArticleId></ArticleIdList></Reference><Reference><Citation>Sotzny F, Blanco J, Capelli E, Castro-Marrero J, Steiner S, Murovska M, et al. Myalgic encephalomyelitis/chronic fatigue syndrome&#x2014;evidence for an autoimmune disease. Autoimmun Rev. 2018;17(6):601&#x2013;609. doi: 10.1016/j.autrev.2018.01.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2018.01.009</ArticleId><ArticleId IdType="pubmed">29635081</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>